Contact
Please use this form to send email to PR contact of this press release:
Cellectar Initiates DLBCL Cohort in Phase 2 Trial of CLR 131 in Refractory B-Cell Hematologic Cancers
TO:
Please use this form to send email to PR contact of this press release:
Cellectar Initiates DLBCL Cohort in Phase 2 Trial of CLR 131 in Refractory B-Cell Hematologic Cancers
TO: